This list is based on the watchlists of people on Stock Events who follow LAB. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Show more...
FAQ
What is Standard BioTools stock price today?▼
The current price of LAB is $0.67 USD — it has increased by +0.09% in the past 24 hours. Watch Standard BioTools stock price performance more closely on the chart.
What is Standard BioTools stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Standard BioTools stocks are traded under the ticker LAB.
Is Standard BioTools stock price growing?▼
LAB stock has risen by +4.99% compared to the previous week, the month change is a -17.87% fall, over the last year Standard BioTools has showed a -47.76% decrease.
What is Standard BioTools market cap?▼
Today Standard BioTools has the market capitalization of 264.56M
When is the next Standard BioTools earnings date?▼
Standard BioTools is going to release the next earnings report on November 10, 2026.
What were Standard BioTools earnings last quarter?▼
LAB earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.01 USD resulting in a -449.02% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Standard BioTools revenue for the last year?▼
Standard BioTools revenue for the last year amounts to 85.33M USD.
What is Standard BioTools net income for the last year?▼
LAB net income for the last year is -74.9M USD.
How many employees does Standard BioTools have?▼
As of September 04, 2026, the company has 389 employees.
In which sector is Standard BioTools located?▼
Standard BioTools operates in the Health & Wellness sector.
When did Standard BioTools complete a stock split?▼
Standard BioTools has not had any recent stock splits.
Where is Standard BioTools headquartered?▼
Standard BioTools is headquartered in BOSTON, United States.